Tokyo, July 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057914) titled 'Prospective observational study investigating the significance of the epigenetic clock in treatment-naive patients with non-small cell lung cancer receiving immune checkpoint blockade therapy' on July 31.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu University School of Medicine
Condition:
Condition - Non-small cell lung cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to evaluate the association between biological age assessed prior to immune checkpoint blockade therapy and treatment efficacy in patients with...